-
1
-
-
20144363192
-
Cancer Genome Project: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
-
Baxter EJ, Scott LM, Campbell PJ, et al. Cancer Genome Project: acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054-1061.
-
(2005)
Lancet
, vol.365
, pp. 1054-1061
-
-
Baxter, E.J.1
Scott, L.M.2
Campbell, P.J.3
-
2
-
-
17844383458
-
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
-
James C, Ugo V, Couédic JPL, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434:1144-1148.
-
(2005)
Nature
, vol.434
, pp. 1144-1148
-
-
James, C.1
Ugo, V.2
Couédic, J.P.L.3
-
3
-
-
20244369569
-
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
-
Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7:387-397.
-
(2005)
Cancer Cell
, vol.7
, pp. 387-397
-
-
Levine, R.L.1
Wadleigh, M.2
Cools, J.3
-
4
-
-
33646546386
-
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
-
Jamieson CH, Gotlib J, Durocher JA, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-6229.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 6224-6229
-
-
Jamieson, C.H.1
Gotlib, J.2
Durocher, J.A.3
-
5
-
-
27244432586
-
Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2(V617F) in granulocytes
-
Lasho TL, Mesa R, Gilliland DG, Tefferi A. Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2(V617F) in granulocytes. Br J Haematol. 2005;130:797-799.
-
(2005)
Br J Haematol
, vol.130
, pp. 797-799
-
-
Lasho, T.L.1
Mesa, R.2
Gilliland, D.G.3
Tefferi, A.4
-
7
-
-
0037515610
-
Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion
-
Iwasaki-Arai J, Iwasaki H, Miyamoto T, Watanabe S, Akashi K. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. J Exp Med. 2003;197;1311-1322.
-
(2003)
J Exp Med
, vol.197
, pp. 1311-1322
-
-
Iwasaki-Arai, J.1
Iwasaki, H.2
Miyamoto, T.3
Watanabe, S.4
Akashi, K.5
-
8
-
-
0034699390
-
Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines
-
Kondo M, Scherer DC, Miyamoto T, et al. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 2000;407:383-386.
-
(2000)
Nature
, vol.407
, pp. 383-386
-
-
Kondo, M.1
Scherer, D.C.2
Miyamoto, T.3
-
9
-
-
18244384493
-
Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4
-
Hou YH, Srour EF, Ramsey H, Dahl R, Broxmeyer HE, Hromas R. Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Blood. 2005;105:3488-3492.
-
(2005)
Blood
, vol.105
, pp. 3488-3492
-
-
Hou, Y.H.1
Srour, E.F.2
Ramsey, H.3
Dahl, R.4
Broxmeyer, H.E.5
Hromas, R.6
-
10
-
-
0036485175
-
Redefinition of lymphoid progenitors
-
Katsura Y. Redefinition of lymphoid progenitors. Nat Rev Immunol. 2002;2:127-132.
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 127-132
-
-
Katsura, Y.1
|